Abstract
Background
Falls and fall-related injuries are of growing concern among older adults. Use of fall-risk-increasing drugs (FRIDs) is a potentially modifiable risk factor. This narrative review describes randomized controlled trials that focused on interventions to reduce FRID use and examined fall-related outcomes (e.g., falls, fractures, risk of injury) as the primary outcome.
Methods
A comprehensive literature search was conducted to identify eligible studies. Two reviewers screened titles and abstracts and then performed a full-text review of relevant articles. Each study is summarized, and a discussion of strengths and limitations is provided.
Results
7 of 22 trials were included in this narrative review. Two studies used a computerized decision support intervention, three used a health professional-led (pharmacist or geriatrician) intervention, and two were direct medication withdrawal interventions. Three studies showed a reduction in fall-related outcomes (two identified fall injuries using claims data; one used an injury risk prediction score). Of these, only one reported FRID reduction. Of four studies that did not find a reduction in falls, one study reported a significant reduction in FRIDs, two found no reduction, and one did not report on this outcome. Most interventions consisted of a one-time FRID assessment, and most targeted either providers or patients (not both).
Conclusion
Most interventions did not reduce FRID use or change fall-related outcomes. Future studies should test “multi-pronged” intervention strategies that simultaneously target both patients and their providers and include more than a single intervention interaction to reduce this modifiable fall risk factor.
Similar content being viewed by others
References
Hartholt KA, Stevens JA, Polinder S, Van Der Cammen TJM, Patka P. Increase in fall-related hospitalizations in the United States, 2001–2008. J Trauma. 2011;71(1):255–8.
Hill K, Schwarz J, Flicker L, Carroll S. Falls among healthy, community-dwelling, older women: A prospective study of frequency, circumstances, consequences and prediction accuracy. Aust N Z J Public Health. 1999;23(1):41–8.
Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319(26):1701–7.
Sattin RW. Falls among older persons: a public health perspective. Annu Rev Public Health. 1992;13:489–508.
Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc. 2018;66(4):693–8.
Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med. 1997;337(18):1279–84.
Tinetti ME, Williams CS. The effect of falls and fall injuries on functioning in community-dwelling older persons. J Gerontol A Biol Sci Med Sci. 1998;53(2):M112–9.
Phelan EA, Rillamas-Sun E, Johnson L, Lamonte MJ, Buchner DM, Lacroix AZ, et al. Determinants, circumstances and consequences of injurious falls among older women living in the community. Inj Prev. 2020. https://doi.org/10.1136/injuryprev-2019-043499.
Seppala LJ, Wermelink A, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11-371.e17.
de Vries M, Seppala LJ, Daams JG, van de Glind EMM, Masud T, van der Velde N. Fall-risk-increasing drugs: a systematic review and meta-analysis: I. Cardiovascular drugs. J Am Med Dir Assoc. 2018;19(4):371.e1–371.e9.
Haddad YK, Luo F, Karani MV, Marcum ZA, Lee R. Psychoactive medication use among older community-dwelling Americans. J Am Pharm Assoc (2003). 2019;59(5):686–90.
Moxey ED, O’Connor JP, Novielli KD, Teutsch S, Nash DB. Prescription drug use in the elderly: a descriptive analysis. Health Care Financ Rev. 2003;24(4):127–41.
Cameron ID, Dyer SM, Panagoda CE, Murray GR, Hill KD, Cumming RG, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev. 2018;9(9):CD005465.
Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;(9):CD007146.
Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q. Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials. J Am Med Dir Assoc. 2018;19(11):923-935.e2.
Hopewell S, Adedire O, Copsey BJ, Boniface GJ, Sherrington C, Clemson L, et al. Multifactorial and multiple component interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2018;7(7):CD012221.
Kua CH, Mak VSL, Huey Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20(3):362-372.e11.
Thillainadesan J, Gnjidic D, Green S, Hilmer SN. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging. 2018;35(4):303–19.
Lapane KL, Hughes CM, Daiello LA, Cameron KA, Feinberg J. Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes. J Am Geriatr Soc. 2011;59(7):1238–45.
Tamblyn R, Eguale T, Buckeridge DL, Huang A, Hanley J, Reidel K, et al. The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial. J Am Med Inform Assoc. 2012;19(4):635–43.
Blalock SJ, Casteel C, Roth MT, Ferreri S, Demby KB, Shankar V. Impact of enhanced pharmacologic care on the prevention of falls: a randomized controlled trial. Am J Geriatr Pharmacother. 2010;8(5):428–40.
Blalock SJ, Ferreri SP, Renfro CP, Robinson JM, Farley JF, Ray N, et al. Impact of STEADI-Rx: a community pharmacy-based fall prevention intervention. J Am Geriatr Soc. 2020;68(8):1778–86.
Weber V, White A, Mcllvried R. An electronic medical record (EMR)-based intervention to reduce polypharmacy and falls in an ambulatory rural elderly population. J Gen Intern Med. 2008;23(4):399–404.
Boyé NDA, van der Velde N, de Vries OJ, van Lieshout EMM, Hartholt KA, Mattace-Raso FUS, et al. Effectiveness of medication withdrawal in older fallers: results from the improving medication prescribing to reduce risk of falls (IMPROveFALL) trial. Age Ageing. 2017;46(1):142–6.
Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc. 1999;7(7):850–3.
Centers for Disease Control and Prevention (CDC). STEADI stopping elderly accidents, deaths, and injuries. 2020. https://www.cdc.gov/steadi/about.html. Accessed 14 Sep 2020.
Aspinall SL, Hanlon JT, Niznik JD, Springer SP, Thorpe CT. Deprescribing in older nursing home patients: focus on innovative composite measures for dosage deintensification. Innov Aging. 2017;1(2):igx031.
Flodgren G, O'Brien MA, Parmelli E, Grimshaw JM. Local opinion leaders: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2019;24(6):CD000125.
Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev. 2009;8(3):CD001096.
Hannan MT, Gagnon MM, Aneja J, Jones RN, Cupples LA, Lipsitz LA, et al. Optimizing the tracking of falls in studies of older participants: comparison of quarterly telephone recall with monthly falls calendars in the MOBILIZE Boston Study. Am J Epidemiol. 2010;171(9):1031–6.
Hartholt KA, Boyé ND, Van der Velde N, Van Lieshout EM, Polinder S, De Vries OJ, et al. [Cost] effectiveness of withdrawal of fall-risk increasing drugs versus conservative treatment in older fallers: design of a multicenter randomized controlled trial (IMPROveFALL-study). BMC Geriatr. 2011;383(2):129–40.
deprescribing.org. Deprescribing Guidelines and Algorithms. 2020. https://deprescribing.org/resources/deprescribing-guidelines-algorithms. Accessed 27 Aug 2020.
Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.
Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.
Bhasin S, Gill TM, Reuben DB, Latham NK, Ganz DA, Greene EJ, et al. A randomized trial of a multifactorial strategy to prevent serious fall injuries. N Engl J Med. 2020;383(2):129–40.
Paquin AM, Zimmerman K, Rudolph JL. Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf. 2014;13(7):919–34.
Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA. 2018;320(18):1889–98.
Morello RT, Soh S-E, Behm K, Egan A, Ayton D, Hill K, et al. Multifactorial falls prevention programmes for older adults presenting to the emergency department with a fall: systematic review and meta-analysis. Inj Prev. 2019;25(6):557–64.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
Drs. Gray and Phelan are funded by a Centers for Disease Control and Prevention Cooperative Agreement (U01CE002967). Dr. Hanlon receives funding from a VA Health Services Research and Development grant (IIR 18-228).
Conflict of Interest
Shelly Gray, Joseph Hanlon, Elizabeth Phelan, and Zizi Elsisi have no conflicts of interest to declare.
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Availability of Data and Material
Not applicable.
Code Availability
Not applicable.
Author Contributions
JH conducted the literature review. All authors agreed on eligible studies. JH, SG, and ZE summarized and critiqued eligible studies. Authors shared responsibility for drafting the manuscript. All authors interpreted results and reviewed, edited, and approved the final manuscript submitted.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gray, S.L., Elsisi, Z., Phelan, E.A. et al. Interventions to Reduce Fall-Risk-Increasing Drug Use to Prevent Falls: A Narrative Review of Randomized Trials. Drugs Aging 38, 301–309 (2021). https://doi.org/10.1007/s40266-021-00835-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-021-00835-9